The European & Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
APPLY before 21 OCT
EDCTP seeks (up to 7) new members for its Scientific Advisory Committee (SAC) as of JAN 2019. The SAC provides strategic & scientific advice and oversees the scientific integrity of the EDCTP programme.
Impact 2003-2018
Overview of selected EDCTP-funded clinical studies for medical interventions against poverty-related infectious diseases, 2003-2018.
Latest news
EDCTP co-sponsors 'TB Science 2018' - the 49th Union's research preconference
TBScience2018 is the official pre-conference event for the 49th Union World Conference on Lung Health. The scientific conference focuses on basic and translational tuberculosis research. The event takes place at the Marriot Hotel The Hague on 23-24 October 2018. Download programme (PDF) The…
Ebola emergency call September 2018: research response to the DRC outbreak
On 3 September 2018, EDCTP launched a €2.25 million emergency funding initiative in response to Ebola virus disease (EVD) outbreaks in the Democratic Republic of the Congo (DRC). This emergency call was open for proposals for seven days. After three…